Cardiff Oncology Inc
Biotechnology
Healthcare
CRDF
66.53 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.07
52 week high
5.35
high
2.09
52 week low
0.00
low
2.02
growth
-23.88 %
previous Close
2.07
P/E ratio
market cap
162 M
div yield
0
usd
Jun 2025
qoq
revenue
121 K
11.01 %
net incoming
-13.95 M
-3.83 %
eps
0.00 %
-5.00 %
eps surprise
-10.53 %
net profit margin
-11528.10 %
796.00 %
operating incoming
-14.78 M
-2.75 %
net change in cash
-13.31 M
51.38 %
cash on hand
10.78 M
-55.24 %
cost of revenue
0.00 %
top top